- £3.73bn
- £3.66bn
- £3.41bn
- 61
- 51
- 95
- 82
2019 July 31st | 2020 July 31st | 2021 July 31st | 2022 July 31st | 2023 July 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,213 | 2,225 | 3,123 | 3,537 | 3,407 |
Cost of Revenue | |||||
Gross Profit | 790 | 422 | 652 | 787 | 687 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 2,538 | 1,976 | 2,643 | 3,228 | 2,901 |
Operating Profit | 675 | 249 | 480 | 309 | 505 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 663 | 237 | 479 | 304 | 483 |
Provision for Income Taxes | |||||
Net Income After Taxes | 539 | 193 | 391 | 243 | 365 |
Net Income Before Extraordinary Items | |||||
Net Income | 539 | 193 | 391 | 243 | 365 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 539 | 193 | 391 | 243 | 365 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.36 | 2.26 | 3.66 | 4.18 | 3.2 |
Dividends per Share |